Oncology Clinical Development Congress - United Kingdom

Over 120 Oncology Clinical Trials, Clinical Development, Diagnostics Development, and Translational Research experts from Europe, US and Asia

Over 60 outstanding case studies and presentations

2 day conference covering key insights into Cancer Clinical Trials and Personalized Medicine, Companion Diagnostics Development as well as successful development, design and analysis of clinical trials

Interactive exhibition room for networking activities and one-to-one meetings

Oxford Global is proud to present the Oncology Clinical Development Congress to be held on the 10th -11th October 2012, Manchester. It is to be co-located with our 2nd Annual Oncology Biomarker Congress.

Over the 2 days, the event provides a first class educational and networking opportunity for over 120 attendees to gain knowledge and insights into the Oncology Clinical Development market. The event will bring together key scientists and investigators in oncology clinical trials, clinical R&D, adaptive trials, oncology diagnostics development, and translational research from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe.

The programme feature topics on improving safety & risk assessment in Oncology clinical trials and clinical development by implementing biomarkers, manage patient selection & recruitment and identify potential cost savings through successful integration of companion diagnostics and enabling technologies in clinical development. Do not miss out on the opportunity to learn insights on effective development, design and analysis of clinical trials.

This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, analysis of current technologies and their applications, network with their peers and address key industry concerns through a series of cutting edge conference presentations and interactive exhibition room in a professional yet relaxed environment.

More about the Event

Read More

Epigenetics and Stem Cells 2012 - United Kingdom

This exciting 2 day conference will bridge epigenetic mechanisms and stem cell biology. The aim is to bring together researchers of both fields with a focus on the role of epigenetic mechanisms in cellular differentiation and adult stem cell systems.
Topics
. DNA methylation and demethylation in stem cells
. Polycomb complexes in tissue stem cell differentiation
. Establishment of chromatin marks in development
. Epigenetics and cell proliferation
. Noncoding RNAs as epigenetic regulators

Abstracts for oral and poster presentations which fit the conference theme are invited.

Keynote Speaker
Elaine Fuchs (Rockefeller University, US)

Invited speakers
• Salvador Aznar-Benitah (Centre for Genomic Regulation (CRG), Spain)
• Menno Creyghton (Hubrecht Institute, Netherlands)
• Luciano Di Croce (Centre for Genomic Regulation (CRG), Spain)
• Amanda Fisher (Imperial College London, UK)
• Mitchell Guttman (MIT, US)
• Myriam Hemberger (Babraham Institute, UK)
• Chris Ponting (University of Oxford)
• Anjana Rao (La Jolla Institute, US)
• Wolf Reik (Babraham Institute, UK)
• Dirk Schübeler (Friedrich Miescher Institute, Switzerland)
• Michael Weber (University of Strasbourg, France)
• Guoliang Xu (Shanghai Institute for Biological Sciences, China)

More about the Event

Read More

Oncology Clinical Development Congress 2012 - United Kingdom

Over 120 Oncology Clinical Trials, Clinical Development, Diagnostics Development, and Translational Research experts from Europe, US and Asia

Over 60 outstanding case studies and presentations

2 day conference covering key insights into Cancer Clinical Trials and Personalized Medicine, Companion Diagnostics Development as well as successful development, design and analysis of clinical trials

Interactive exhibition room for networking activities and one-to-one meetings

Oxford Global is proud to present the Oncology Clinical Development Congress to be held on the 10th -11th October 2012, Manchester. It is to be co-located with our 2nd Annual Oncology Biomarker Congress.

Over the 2 days, the event provides a first class educational and networking opportunity for over 120 attendees to gain knowledge and insights into the Oncology Clinical Development market. The event will bring together key scientists and investigators in oncology clinical trials, clinical R&D, adaptive trials, oncology diagnostics development, and translational research from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe.

The programme feature topics on improving safety & risk assessment in Oncology clinical trials and clinical development by implementing biomarkers, manage patient selection & recruitment and identify potential cost savings through successful integration of companion diagnostics and enabling technologies in clinical development. Do not miss out on the opportunity to learn insights on effective development, design and analysis of clinical trials.

This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, analysis of current technologies and their applications, network with their peers and address key industry concerns through a series of cutting edge conference presentations and interactive exhibition room in a professional yet relaxed environment.

Further details and to register

Read More

Conference on Epigenetics and Stem Cells 2012 - United Kingdom

This exciting 2 day conference will bridge epigenetic mechanisms and stem cell biology. The aim is to bring together researchers of both fields with a focus on the role of epigenetic mechanisms in cellular differentiation and adult stem cell systems.
Topics
. DNA methylation and demethylation in stem cells
. Polycomb complexes in tissue stem cell differentiation
. Establishment of chromatin marks in development
. Epigenetics and cell proliferation
. Noncoding RNAs as epigenetic regulators

Abstracts for oral and poster presentations which fit the conference theme are invited.

Keynote Speaker
Elaine Fuchs (Rockefeller University, US)

Invited speakers
• Salvador Aznar-Benitah (Centre for Genomic Regulation (CRG), Spain)
• Menno Creyghton (Hubrecht Institute, Netherlands)
• Luciano Di Croce (Centre for Genomic Regulation (CRG), Spain)
• Amanda Fisher (Imperial College London, UK)
• Mitchell Guttman (MIT, US)
• Myriam Hemberger (Babraham Institute, UK)
• Chris Ponting (University of Oxford)
• Anjana Rao (La Jolla Institute, US)
• Wolf Reik (Babraham Institute, UK)
• Dirk Schübeler (Friedrich Miescher Institute, Switzerland)
• Michael Weber (University of Strasbourg, France)
• Guoliang Xu (Shanghai Institute for Biological Sciences, China)

Further details and to register

Read More

Drug Design 2012 at United Kingdom

DrugDesign 2012 - Oxford’s first structure-based drug design conference - will address the latest developments in computational and experimental approaches to ligand- and structure-based drug design. This conference is aimed at bringing together scientists from academia and industry to stimulate and step up the development of cutting-edge in silico and experimental drug design approaches. The conference invites podium and poster proposals in the following general areas of drug design:-

Molecular modelling and simulation
Novel drugable targets: Identification and selection
Fragment binding and selectivity
Structure-based inhibitor design
Ligand design and identification
Target-ligand interaction (including proteins and nucleic acids)
In silico and experimental screening technologies

Who Should Attend

Academia: Lab heads, postdoctoral researchers, graduate research students
Industry: Team leaders, junior researchers, research managers and decision makers

Further details and to register

Read More

10th Annual Pharmaceutical IT Congress 2012 at UK

*Over 150 attendees working in Enterprise IT, Clinical IT and Data Management*

*Over 40 case studies, presentations and panel discussions*

*4 interactive streams: *
- 2x Enterprise IT streams
- R&D IT
- Data Management

*14 prescheduled one to one business meetings & exhibitions*

This long-standing and prestigious congress is designed to offer clear and informed insights into enterprise IT, R&D IT and data management. The event will cover the pressing concerns and relevant challenges facing leading pharmaceutical organisations, biotech companies and academic institutions.

Over the two days, key opinion leaders will explore pioneering solutions and critical opportunities in information management, systems flexibility and research and development IT. Delegates will hear from those working at the forefront of information technology in areas such as cloud computing and semantic web technologies, while internationally recognised experts present sustainable strategies for long-term success in data management, process infrastructure and pre-competitive collaboration.

Further details and to register

Read More

Europhages 2012: Bacteriophage in Medicine, Food and Biotechnology, UK

 Welcome to the Oxford Bacteriophage Conference, EuroPhages 2011. The conference will address commercial and research applications of bacteriophage in medicine, food and biotechnology, and invites proposals for podium and poster presentation in the following general areas:

• Pharmaceutical production of bacteriophage
• Medical applications of bacteriophage
• Immunogenicity and toxicology
• Bacteriophage in biotechnology
• Bacteriophage in food technology
• Bacteriophage molecular biology

Who Should Attend

Academic, Research and Healthcare: Group and Lab Heads, Postdoctoral Scientists and Graduate Research Students, Research Managers, Physicians and Healthcare Workers

Biotech and Pharma: CEOs, Chief Scientists, Group Heads and Team Leaders, Senior and Junior Research Scientists, Research Managers

Further details and to register

Read More

UK Influenza 2012: One Influenza, One World

Welcome to Influenza2012

Bringing together human and veterinary influenza researchers

The Oxford influenza conference, Influenza 2012, will address most aspects of basic and applied research on zoonotic and human influenza viruses and their medical and socio-economic impact. The conference invites proposals for podium presentation and posters in the following general areas:-

• Molecular virology and immunology
• Antiviral drug development and treatment strategies, including vaccination
• Host-pathogen interaction - virulence and pathogenecity
• Epidemiology and evolution
• Mathematical models
• National and international surveillance and contingency strategies
• Advances in viral detection and identification technologies 

Further details and to register

Read More

Venoms 2012: Bioactive Compounds and Therapeutics

Venoms offer a substantial pool of bioactive compounds with therapeutic and pharmacological potential. The 1st Oxford World Symposium on Venoms, Venoms 2012, is aimed at providing an international platform to scientists from academia, industry and clinical settings to discuss and explore this huge reservoir of potential lead compounds for drug development. The conference will also discuss the development of anti-venoms vaccines and envenomation treatment strategies.

Venoms 2012 invites proposals for podium sessions in the general areas of:
• Isolation of bioactive lead compounds from venoms for drug development
• Anti-venom vaccines and therapeutics
• Envenomation treatment strategies
• Venoms in warfare
• Envenomation as a neglected tropical disease

Further details and to register

Read More

73rd Harden - Machines on genes II - The central dogma at the interface of biology, chemistry and physics - United Kingdom

The replication, maintenance and transcription of the genome require an array of protein machines including polymerases, helicases, translocases, nucleases, recombinases and topoisomerases, often functioning as components of multi-protein complexes. Machines on Genes II will bring together scientists with an interest in multi- and inter-disciplinary approaches for unravelling the anatomy, architecture and mechanisms of these remarkable molecular machines. The conference will cover topics in DNA replication, recombination, repair and transcription and will showcase the latest work of world leaders in the fields of structural biology, chemical biology and novel biophysical methods including single-molecule detection.



 Further Event Details

Read More

USA 2012: Life Science Legal & Business Strategy Conference

 GTC’s Life Science Legal & Business Strategy Conference provides executive level insight into the legal issues of greatest concern in today’s business environment. Respected litigators, counselors, advisors and industry professionals offer in depth knowledge and perspectives into the latest regulatory changes and how to develop plans to protect your organization and its products as well as exploit opportunities that may only exist for a limited time. The summit takes place in San Diego, CA on Jun 07-08, 2012.

Further Conference Details

Read More

2012 Histopathology Event: Advances in research and techniques, UK

This is the 9th Annual event (originally called Improving Immunohistochemistry) and is the flagship meeting for Euroscicon. Held in the centre of London this meeting draws together international experts to discuss the need for technical-based updates in the areas of immunohistochemistry, clinical and research based histopathology and in situ hybridisation. This meeting gathers together workings from clinical, academic and pharmaceutical organisations.

Conference Website

Read More

UK: 2nd Annual Regulatory Cells in Autoimmunity event: Analysing and moderating function

After our first very successful meeting we are pleased to announce our 2nd Annual Regulatory Cells in Autoimmunity event: Analysing and moderating function which will take place in London on 6th December 2012

This event has CPD accreditation and will have a discussion panel session.

Meeting Chairs: Dr Elizabeth Jury , UCL, London, Professor Robert Barker, University of Aberdeen

On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event

 Conference Website

Read More

RNAi2012: Gene Regulation by Small RNAs, United Kingdom

Oxford academic RNAi conferences offer best scientific programme in Europe, attracting a global participation of leading scientists from academia and industry, postdoctoral researchers and students. These conferences provide an excellent opportunity to establish new collaborative links with academic and industrial colleagues and to find a PhD or a postdoctral position.

The 7th Annual Oxford RNAi Conference, RNAi2011, will address the biology and application of RNA interference, and welcomes proposals on endogenous and exogenous roles of small RNAs in gene regulation, health and disease.

Who Should Attend

Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students

Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads and Team Leaders, Senior and Junior Research Scientists, Research Managers

More Info

Read More

European Algae Biomass Summit 2012 - United Kingdom

Following the success of this year’s European Algae Biomass Summit 2011 we are delighted to confirm the dates and venue of next year’s event as 25th – 26th April 2012 in London, UK. The 2012 European Algae Biomass Conference will include opportunities to hear from leading industry executives and experts, including; Algae Producers, Green Energy and Biotech Investors, Biodiesel Manufacturers, Cultivation, Harvesting and Oil Extraction Process Technology Providers, Government Representatives and other Industry Professionals.

Over the two days we will provide you with excellent opportunities to interact with your peers in constructive and informative round table and panel discussions. During these sessions you can express your views and participate in discussions about current and future industry activity, this will also be one of many chances to have your questions answered by industry professionals, providing you with the answers you want and need. You can listen in on informative and insightful presentations by the leading figures in the algae industry and maximise your contacts and build strong relationships to open up new and exciting business ventures.

Key Areas of Discussion

• European Market Insight
• Potential and Future Outlook for Emerging Markets
• Investment from an Investor’s Perspective
• An Insight Into the Key Aspects of Environmental Law & Regulation
• Analysis of the Current Cultivation Methods Used
• An In-Depth Comparison of Harvesting & Oil Extraction Techniques
• Algae Production: Case Study Examples
• Cutting-Edge Research & Development Activities
• Algae Potential in CO2 Sequestration & Wastewater Treatment
• Algae Supply Chain Analysis
• Life Cycle Analysis of Algae Biofuel

Who will attend?

Algae Production Plants, Green Energy and Biotech Investors, Biodiesel Manufacturers, Technology Providers, Biofuel Producers, Government Representatives, Algae Plant Project Managers and Construction Professionals, Lawyers and Legal Firms, Leading Algae R&D Organisations

For additional information and registration

Read More

Meeting on Origins of Tissue Stem Cells, Edinburgh UK 2012

Determining the origin of tissue stem/progenitor cells is key to our understanding of developmental biology. This meeting will focus on how and when self-renewing tissue stem cells arise during embryonic development. We will discuss common features between different stem cell lineages, and examine how modelling can inform in vivo studies. Join us in Edinburgh to learn more, exchange ideas and accelerate discoveries with leading scientists in this field.

Presentation opportunities!Talk and poster slots are available. Submit your abstract for the chance to present to leading scientists.

• Oral abstract deadine: March 23, 2012
• Poster abstract deadine: April 23, 2012

 Read More about The event

Read More

2nd Annual Vaccines Congress 2012 - United Kingdom 2012

Oxford Global Conferences is proud to present its 2nd Annual Vaccines Congress 2012, which is to be held on the 2nd & 3rd April at the Copthorne Tara Hotel in London, UK. The congress is the single most focused event in Europe dedicated to assess key technological and scientific strategies in the pharmaceutical and biotech industry, as well as academic institutions in vaccines discovery and development. It will also be co-located with our 5th Proteins Congress 2012.

The vaccine market has become one of the largest growth areas in the healthcare industry and vaccines role in public health preparedness grows ever more with immunisation being one of the greatest achievements. This congress will provide up to date insights into the discovery and development of vaccine candidates for diseases. It will also cover current developments in Vaccine process development and production, new and novel technologies for Vaccines design, development and delivery, as well as implementation of successful clinical trials. Attendees at the event will benefit from strategies to lower cost and time to first dose, increase yield and optimise pipeline in Vaccines Discovery and Development.

Do not miss out on our co-located congress 5th Annual Proteins Congress 2012, which is the single most focused event in Europe dedicated to key technological and scientific trends in Proteins in the pharmaceutical and biotech industry.

 Read More about The event

Read More

5th Annual Proteins Congress 2012 - United Kingdom 2012

Over 175 attendees working within proteins, antibodies and biotherapeutics

Over 40 case studies, presentations and panel discussions

4 interactive streams:
• Protein Purification, Expression & Characterisation
• Antibodies
• Biotherapeutics
• Immunogenicity

Co-Located with our 2nd Annual Vaccines Congress 2012

14 prescheduled one to one business meetings & exhibitions

Oxford Global Conferences are proud to present the 5th Annual Proteins Congress 2012, which is to be held on the 2nd & 3rd April at the Copthorne Tara Hotel, London, UK. Centered around the key topic areas of Protein Science, Protein Technologies, Expression, Characterisation, Engineering and Production, the event is the single most focused proteins event in Europe. The congress highlights opportunities in the protein and antibody market by focusing on current trends, technologies and business models. The event will also address relevant challenges and bottlenecks, for example, the new Immunogenicity stream offers practical strategies for dealing with one of the industry’s biggest challenges.

The event is co-located with the 2nd Annual Vaccines Congress which offers up to date insights into the discovery and development of vaccine candidates for diseases. Topics include new technologies for Vaccines design and delivery and strategies to increase yields, optimise pipelines and successfully implement clinical trails.

Read More about The event

Read More

Driving Stem Cell Research Towards Therapy - Symposium 2012 UK

2012 is an historic year for the MRC Centre for Regenerative Medicine as we celebrate the official opening of the new Scottish Centre for Regenerative Medicine Building and the culmination of the remarkable scientific career of Professor Sir Ian Wilmut OBE FRS. To mark these two important events we are holding an International Scientific Symposium in Edinburgh on May the 21st and 22nd 2012.

The symposium entitled “Driving Stem Cell research Towards Therapy” will bring together an outstanding list of international experts in stem cell biology and regenerative medicine. The 2 day meeting includes a special session to specifically honour Sir Ian’s contribution with keynote presentations from fellow reprogramming pioneers Shinya Yamanaka and Sir John Gurdon.

The meeting will be held in the John McIntyre Conference Centre with discounted en-suite on-site accommodation available and within easy reach of the City Centre and transport links.

To register please visit US

Read More

Scientific Conferences on Genomic Disorders 2012: The Genomics of Rare Diseases

Building on the success of the annual Genomic Disorders meetings held at Hinxton since 2007, Genomic Disorders 2012 presents an exciting blend of genomic science and clinical medicine. Our meeting aims to bring together scientists and clinicians interested in genomic variation in humans and the mechanisms by which it exerts its phenotypic effects.

This year’s meeting will discuss the latest findings relating to the genomic basis of rare disorders, and the role of rare variants in common disease, as these can provide such powerful insights into human biology. Genome wide analyses, including most recently Whole Exome Sequencing, are proving to be of great value in discovering the genetic basis of rare disorders and illustrate the power of humans as a model organism to study. As sequencing technology advances apace, other key aspects of genome science need to develop and grow in parallel.

These include: analysis (interpretation of sequence and copy number variants including assessment of clinical and biological impact and the elucidation/discernment of what constitutes medically actionable variants), ethics (what to do with incidental findings generated by whole genome research studies) and policy (stewardship and access to genomic data in research and healthcare); GD2012 will feature scientific sessions in these key areas.

The meeting will take place at the Wellcome Trust Conference Centre, in the convivial setting of the Hinxton Genome Campus where some of the world's leading scientists can discuss advances in their field and learn about recent progress in others.

Additional speakers will be selected to speak from submitted abstracts

The conference will open with registration at 15:00 followed by talks from 17:00 on the Wednesday, 21 March.
The conference will close after dinner on the Friday, 23 March, with just departures on the morning of the Saturday, 24 March.

To view the full  Details please click here

Read More